FDA
-
-
-
-
-
-
-
Phio Pharmaceuticals Announces Presentation at Centri Capital Conference on April 14, 2026
-
-
-
-
-
-
-
Phio Pharmaceuticals to Present at the Life Sciences Investor Forum on March 12, 2026, 11 AM EDT
-
-
-
-
-
-
-
Phio Pharmaceuticals Reports 2024 Year End Financial Results and Provides Business Update
-
-
-
-
-
-
-
Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series
-
-
-
-
-
-
-
Phio Pharmaceuticals Announces Promising Results of Second Cohort from Its Ongoing Clinical Study of PH-762
-
-
-
-
-
-
-
Phio Pharmaceuticals Corp. (PHIO) Announces Positive Safety Monitoring Committee (SMC) Recommendation to Continue to Third Dose Cohort in its Clinical Study of PH-762
-
-
-
-
-
-
-
Phio Pharmaceuticals Announces Upcoming Presentation at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
-
322,743 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

